GGrantIndex
← Leaderboards

Amit Gaggar

University Of Alabama At Birmingham

$7,818,359
Attributed
$9,961,266
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,961,266 · 5
VA$0 · 2

By mechanism

R01$7,036,042 · 3
T32$2,237,480 · 1
P30$687,744 · 1
I01$0 · 2

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Glycine

Research focus

GlycineProlineCollagenTherapeutic TargetInflammatoryGenerationsPeptide HydrolasesIn VitroExtracellular MatrixMorbidity - Disease RateChronicLung DiseasesPathway InteractionsInflammationMortalityPathogenesisProlyl OligopeptidaseIn VivoAirway InflammationCause Of DeathBiological MarkersPlayLungNeutrophil

Grant awards (35)

Training Program in Lung Biology and Translational Medicine$246,333
T32 · FY2025 · HL · contact PI
UAB CFRC Pilot and Feasibility Program$229,248
P30 · FY2025 · DK · contact PI
Neutrophil Exosomes: New Pathogenic Entities in COPD$0
I01 · FY2025 · VA · contact PI
Training Program in Lung Biology and Translational Medicine$436,177
T32 · FY2024 · HL · contact PI
UAB CFRC Pilot and Feasibility Program$229,248
P30 · FY2024 · DK · contact PI
Role of heme and PGP matrikines in lung inflammation$547,169
R01 · FY2023 · HL
Training Program in Lung Biology and Translational Medicine$384,611
T32 · FY2023 · HL · contact PI
UAB CFRC Pilot and Feasibility Program$229,248
P30 · FY2023 · DK · contact PI
Neutrophil Exosomes: New Pathogenic Entities in COPD$0
I01 · FY2023 · VA · contact PI
Role of heme and PGP matrikines in lung inflammation$547,169
R01 · FY2022 · HL
Training Program in Lung Biology and Translational Medicine$344,150
T32 · FY2022 · HL · contact PI
Neutrophil Exosomes: New Pathogenic Entities in COPD$0
I01 · FY2022 · VA · contact PI
Role of heme and PGP matrikines in lung inflammation$547,169
R01 · FY2021 · HL
Training Program in Lung Biology and Translational Medicine$504,563
T32 · FY2021 · HL · contact PI
A Novel Proteolytic System of Pulmonary Inflammation$371,250
R01 · FY2021 · HL · contact PI
Neutrophil Exosomes: New Pathogenic Entities in COPD$0
I01 · FY2021 · VA · contact PI
Role of heme and PGP matrikines in lung inflammation$547,169
R01 · FY2020 · HL
A Novel Proteolytic System of Pulmonary Inflammation$371,250
R01 · FY2020 · HL · contact PI
Neutrophil Exosomes: New Pathogenic Entities in COPD$0
I01 · FY2020 · VA · contact PI
A Novel Proteolytic System of Pulmonary Inflammation$371,250
R01 · FY2019 · HL · contact PI
Training Program in Lung Biology and Translational Medicine$321,646
T32 · FY2019 · HL · contact PI
Genetics of Smoke-Altered LTA4H in COPD$390,354
R01 · FY2018 · HL
A Novel Proteolytic System of Pulmonary Inflammation$371,250
R01 · FY2018 · HL · contact PI
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPD$0
I01 · FY2018 · VA · contact PI
Genetics of Smoke-Altered LTA4H in COPD$390,354
R01 · FY2017 · HL
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPD$0
I01 · FY2017 · VA · contact PI
Genetics of Smoke-Altered LTA4H in COPD$390,354
R01 · FY2016 · HL
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPD$0
I01 · FY2016 · VA · contact PI
Genetics of Smoke-Altered LTA4H in COPD$401,792
R01 · FY2015 · HL
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPD$0
I01 · FY2015 · VA · contact PI
A novel proteolytic system of pulmonary inflammation$357,786
R01 · FY2014 · HL · contact PI
A novel proteolytic system of pulmonary inflammation$346,457
R01 · FY2013 · HL · contact PI
A novel proteolytic system of pulmonary inflammation$341,090
R01 · FY2012 · HL · contact PI
A novel proteolytic system of pulmonary inflammation$366,277
R01 · FY2011 · HL · contact PI
A novel proteolytic system of pulmonary inflammation$377,902
R01 · FY2010 · HL · contact PI